PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8940037-2	1996	In both cell lines, insulin significantly increased p21(ras).GTP loading (1.5-2-fold) and MAP kinase activity (5-8-fold).	Guanosine Triphosphate	61-64	cyclin-dependent kinase inhibitor 1A (P21)	Mus musculus	52-55	
8940037-3	1996	Inhibition of Ras farnesylation with lovastatin blocked activation of p21(ras) and Raf-1 kinase in both 3T3-L1 fibroblasts and 3T3-L1 adipocytes.	Lovastatin	37-47	cyclin-dependent kinase inhibitor 1A (P21)	Mus musculus	70-73	
8940037-3	1996	Inhibition of Ras farnesylation with lovastatin blocked activation of p21(ras) and Raf-1 kinase in both 3T3-L1 fibroblasts and 3T3-L1 adipocytes.	Lovastatin	37-47	v-raf-leukemia viral oncogene 1	Mus musculus	83-88	
8940037-5	1996	In contrast, in 3T3-L1 adipocytes, despite an inhibition of activation of p21(ras) and Raf-1 by lovastatin, insulin continued to stimulate MAP kinase activity.	Lovastatin	96-106	cyclin-dependent kinase inhibitor 1A (P21)	Mus musculus	74-77	
8940037-5	1996	In contrast, in 3T3-L1 adipocytes, despite an inhibition of activation of p21(ras) and Raf-1 by lovastatin, insulin continued to stimulate MAP kinase activity.	Lovastatin	96-106	v-raf-leukemia viral oncogene 1	Mus musculus	87-92	
8940037-6	1996	Fractionation of the cell lysates on the FPLC Mono-Q column revealed that lovastatin inhibited insulin stimulation of ERK2 (and, to a lesser extent, ERK1) in 3T3-L1 fibroblasts and had no effect on the insulin-stimulated ERK2 in 3T3-L1 adipocytes.	Lovastatin	74-84	mitogen-activated protein kinase 1	Mus musculus	118-122	
8940037-6	1996	Fractionation of the cell lysates on the FPLC Mono-Q column revealed that lovastatin inhibited insulin stimulation of ERK2 (and, to a lesser extent, ERK1) in 3T3-L1 fibroblasts and had no effect on the insulin-stimulated ERK2 in 3T3-L1 adipocytes.	Lovastatin	74-84	mitogen-activated protein kinase 3	Mus musculus	149-153	
8940037-6	1996	Fractionation of the cell lysates on the FPLC Mono-Q column revealed that lovastatin inhibited insulin stimulation of ERK2 (and, to a lesser extent, ERK1) in 3T3-L1 fibroblasts and had no effect on the insulin-stimulated ERK2 in 3T3-L1 adipocytes.	Lovastatin	74-84	mitogen-activated protein kinase 1	Mus musculus	221-225